OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
FATE holding history
Fate Therapeutics Inc in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FATE overviewAll 13F holders of FATEFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −1,680,580−100.0% | Sold out | Holders |
| Q1 2025 | 1,680,580 | $1.33M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,680,580 | $2.77M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,680,580 | $5.88M | 0.1% | +325,228+24.0% | Added | Holders |
| Q2 2024 | 1,355,352 | $4.45M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,355,352 | $9.95M | 0.2% | +827,272+156.7% | Added | Holders |
| Q4 2023 | 528,080 | $1.98M | <0.1% | +528,080 | New | Holders |